US ingredients group Martek Biosciences saw profits increase in its second quarter driven by revenue growth in Asia.
Net income rose to US$12.5m for the three months to the end of March, from $11m in the prior year.
Go deeper with GlobalData
Revenues for the second quarter increased 34% to reach $124m.
Both revenues and earnings included the results of Amerifit Brands, which the firm acquired in February.
CEO Steve Dubin said: “The improving economy, new launches of products with Martek’s life’sDHA, growing international markets for Martek’s products and sales of Amerifit’s branded consumer health products all contributed to Martek’s record quarterly results.”
See Also:
Dubin added: “Demand increases outside the US, particularly in Asia, were a key driver of this growth. We believe that a portion of the nutritional ingredient revenue increase.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
